Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	23.14	340.24	-276.31
Graham Fair Price	20.43	0.59	0.49
PEG	38.26	5.70	4.12
Price/Book	-34.88	3.18	4.89
Price/Cash Flow	46.04	293.26	-200.81
Prices/Earnings	-45.07	107.71	196.07
Price/Sales	-62.52	20.92	55.82
Price/FCF	46.04	293.26	-200.81
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	19.34	0.19	0.16
Operating Margin	-54.49	0.06	0.13
ROA	19.17	< 0.005	< 0.005
ROE	< 0.005	< 0.005	18.53
ROIC	< 0.005	< 0.005	17.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.18	0.30	-38.63
Dividends QOQ	-0.22	0.61	175.73
EBIT QOQ	1.36	-0.20	-84.97
EPS QOQ	0.48	0.19	-60.27
FCF QOQ	-1.96	1.45	-25.93
Revenue QOQ	-0.35	0.75	115.23
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	194.62	114.24	-41.30
Days Sales Outstanding (DSO)	242.52	142.96	-41.05
Inventory Turnover	0.46	0.79	70.37
Debt/Capitalization	0.02	0.02	-18.59
Quick Ratio	5.52	5.97	8.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.31	1.45	10.62
Cash	0.40	0.44	11.11
Capex	< 0.005	< 0.005	-67.68
Free Cash Flow	-0.03	0.02	-50.68
Revenue	0.11	0.22	92.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	7.19	7.70	7.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.76	-33.53	100.13
Naive Interpretation	Member

06 - Financial Health · Bad

Rating